Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation-Reference-Cited by-同舟云学术

Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation

Published:2020-05 Issue:3 Volume:27 Page:e270-e285
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Aronow Wilbert S.,Shamliyan Tatyana A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference132 articles.

1. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation;John Camm;Eur Heart J.,2012

2. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association;Sacco;Stroke.,2013

3. Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology;Culebras;Neurology.,2014

4. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation : executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;January;Circulation.,2014

5. FDA Cardiovascular and Renal Drugs Advisory Committee. XARELTO® (rivaroxaban) Tablets;Indication for Use: Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Influencing Factors of Compliance with Non-Vitamin K Antagonist Oral Anticoagulant in Patients with Nonvalvular Atrial Fibrillation and Correlation with the Severity of Ischemic Stroke;Evidence-Based Complementary and Alternative Medicine;2021-10-19

2. Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews;Drug Safety;2019-09-24